Title: Assembly Amendment to Assembly Bill No. 284 First Reprint (BDR S-571)
Official Title: Assembly Amendment to Assembly Bill No. 284 First Reprint (BDR S-571)
Number of Sections: 1
Source: versions - Amendment 893
Media Type: application/pdf
Strikethrough Detection: 3 sections found

================================================================================

Section 1:
2025 Session (83rd) A AB284 R1 893
Amendment No. 893
Proposed by: Assembly Committee on Ways and Means
Amends: Summary: No Title: Yes Preamble: No Joint Sponsorship: No Digest: Yes
ASSEMBLY ACTION Initial and Date | SENATE ACTION Initial and Date
Adopted Lost | Adopted Lost
Concurred In Not | Concurred In Not
Receded Not | Receded Not
EXPLANATION: Matter in (1) blue bold italics is new language in the original
bill; (2) variations of green bold underlining is language proposed to be added in
this amendment; (3) red strikethrough is deleted language in the original bill; (4)
purple double strikethrough is language proposed to be deleted in this amendment;
(5) orange double underlining is deleted language in the original bill proposed to be
retained in this amendment.
-
DAN/EWR Date: 5/29/2025
A.B. No. 284—Requires the Director of the Department of Health and Human
Services to seek to establish certain rates of reimbursement
under Medicaid for certain devices to treat epilepsy.
(BDR S-571)
*A_AB284_R1_893*
Page 1 of 4
Assembly Amendment No. 893 to Assembly Bill No. 284 First Reprint Page 3
ASSEMBLY BILL NO. 284–ASSEMBLYMEMBER BROWN-MAY
FEBRUARY 25, 2025
_______________
Referred to Committee on Health and Human Services
SUMMARY—Requires the Director of the Department of Health and Human
Services to seek to establish certain rates of reimbursement
under Medicaid for certain devices to treat epilepsy.
(BDR S-571)
FISCAL NOTE: Effect on Local Government: No.
Effect on the State: Yes.
~
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
AN ACT relating to Medicaid; requiring the Director of the Department of Health
and Human Services to seek to establish certain rates of reimbursement
under Medicaid for vagus nerve stimulation therapy devices,
replacement parts for such a device and the procedures necessary to
implant, repair or replace a part of such a device; making an
appropriation; and providing other matters properly relating thereto.
Legislative Counsel’s Digest:
1 Existing law requires the Department of Health and Human Services to administer the
2 Medicaid program. (NRS 422.270) [This] Section 2 of this bill requires the Director of the
3 Department to submit to the United States Secretary of Health and Human Services a request
4 to [amend] include under Medicaid to provide rates of reimbursement greater than or equal to
5 82 percent of the cost for: (1) a vagus nerve stimulation therapy device [;] prescribed for the
6 treatment of epilepsy; (2) any replacement part for such a device; and (3) the procedure
7 necessary to implant, repair or replace a part of such a device. [This bill] Section 2 also
8 clarifies that the rates of reimbursement established for the cost of a vagus nerve stimulation
9 therapy device and any replacement part for such a device must be separate from and in
10 addition to the rates of reimbursement for medical care necessary for the implantation or
11 repair of such a device or the replacement of a part for the device. Section 1 of this bill
12 makes an appropriation to and authorizes expenditures by the Division of Health Care
13 Financing and Policy of the Department for certain costs associated with making the
14 increases to rates of reimbursement under Medicaid required by section 2.
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
1 Section 1. 1. There is hereby appropriated from the State General
2 Fund to the Division of Health Care Financing and Policy of the Department
3 of Health and Human Services for carrying out the provisions of section 2 of
Assembly Amendment No. 893 to Assembly Bill No. 284 First Reprint Page 4
1 this act and making upgrades to computer systems necessary to carry out
2 those provisions the following sums:
3 For the Fiscal Year 2025-2026 ....................................................... $54,728
4 For the Fiscal Year 2026-2027 ..................................................... $240,004
5 2. Any balance of the sums appropriated by subsection 1 remaining at
6 the end of the respective fiscal years must not be committed for expenditure
7 after June 30 of the respective fiscal years by the entity to which the
8 appropriation is made or any entity to which money from the appropriation is
9 granted or otherwise transferred in any manner, and any portion of the
10 appropriated money remaining must not be spent for any purpose after
11 September 18, 2026, and September 17, 2027, respectively, by either the entity
12 to which the money was appropriated or the entity to which the money was
13 subsequently granted or transferred, and must be reverted to the State
14 General Fund on or before September 18, 2026, and September 17, 2027,
15 respectively.
16 3. Expenditure of the following sums not appropriated from the State
17 General Fund or the State Highway Fund is hereby authorized by the Division
18 of Health Care Financing and Policy of the Department of Health and Human
19 Services for the same purposes as set forth in subsection 1:
20 For the Fiscal Year 2025-2026 ..................................................... $188,270
21 For the Fiscal Year 2026-2027 ..................................................... $700,098
22 [Section 1.] Sec. 2. 1. On or before October 1, 2025, the Director of the
23 Department of Health and Human Services shall submit to the United States
24 Secretary of Health and Human Services a request to include under Medicaid:
25 (a) A rate of reimbursement for a vagus nerve stimulation therapy device
26 prescribed for the treatment of epilepsy that is greater than or equal to 82 percent
27 of the acquisition cost of such a device;
28 (b) A rate of reimbursement for any replacement part for a vagus nerve
29 stimulation therapy device prescribed for the treatment of epilepsy that is greater
30 than or equal to 82 percent of the acquisition cost of such a replacement part; and
31 (c) A rate of reimbursement for the procedure necessary to implant, repair or
32 replace a part of a vagus nerve stimulation therapy device prescribed for the
33 treatment of epilepsy that is greater than or equal to 82 percent of the cost of the
34 procedure.
35 2. The rates of reimbursement established pursuant to paragraphs (a) and (b)
36 of subsection 1 must be separate from and in addition to the rates of reimbursement
37 for the medical care necessary for implantation or repair of a vagus nerve
38 stimulation therapy device or the replacement of a part for such a device.
39 3. The request submitted pursuant to subsection 1 must be supported using
40 methods for determining rates of reimbursement accepted by the Secretary.
41 [Sec. 2.] Sec. 3. 1. This [act becomes] section and section 1 of this act
42 become effective [upon passage and approval.] on July 1, 2025.
43 2. Section 2 of this act becomes effective on March 1, 2026.
[DELETED:   A  D  ( T P J DN SI  IA L   | A L  C N   | C N  R N   | R N  ]
[DELETED:  PBN.AB-M I O S RNA2  t D o t D o H a H t s t e c r o r M f c d t t e EE M f v n s t d r o r a p o s a d m aE   S 1  1  T i h a f t S G F o]
[DELETED:  P t a a m u t c s n t c o t F F  2  A t a J 3 o t r f y b t e t w t a g o o t i a m a a p o t a m r m n b s f a p a S t s g o t a m b r t t S G F o o b S 1 2 a S 1 2 r  3  E G o S F F  [ 1  S 2  1  O D o H a H S s s t t U S S  ( A r o r f a v n s t d p o  ( A r o r f a r p f a v n s t  ( A r a p o a v n s d p f t t p  2  T o f t m c n f i o r o a v n s  3  T m  [ 2  S 3  1  T b  2  S]


================================================================================

Raw Text:
2025 Session (83rd) A AB284 R1 893
Amendment No. 893
Assembly Amendment to Assembly Bill No. 284 First Reprint (BDR S-571)
Proposed by: Assembly Committee on Ways and Means
Amends: Summary: No Title: Yes Preamble: No Joint Sponsorship: No Digest: Yes
ASSEMBLY ACTION Initial and Date | SENATE ACTION Initial and Date
Adopted Lost | Adopted Lost
Concurred In Not | Concurred In Not
Receded Not | Receded Not
EXPLANATION: Matter in (1) blue bold italics is new language in the original
bill; (2) variations of green bold underlining is language proposed to be added in
this amendment; (3) red strikethrough is deleted language in the original bill; (4)
purple double strikethrough is language proposed to be deleted in this amendment;
(5) orange double underlining is deleted language in the original bill proposed to be
retained in this amendment.
-
DAN/EWR Date: 5/29/2025
A.B. No. 284—Requires the Director of the Department of Health and Human
Services to seek to establish certain rates of reimbursement
under Medicaid for certain devices to treat epilepsy.
(BDR S-571)
*A_AB284_R1_893*
Page 1 of 4

Assembly Amendment No. 893 to Assembly Bill No. 284 First Reprint Page 3
ASSEMBLY BILL NO. 284–ASSEMBLYMEMBER BROWN-MAY
FEBRUARY 25, 2025
_______________
Referred to Committee on Health and Human Services
SUMMARY—Requires the Director of the Department of Health and Human
Services to seek to establish certain rates of reimbursement
under Medicaid for certain devices to treat epilepsy.
(BDR S-571)
FISCAL NOTE: Effect on Local Government: No.
Effect on the State: Yes.
~
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
AN ACT relating to Medicaid; requiring the Director of the Department of Health
and Human Services to seek to establish certain rates of reimbursement
under Medicaid for vagus nerve stimulation therapy devices,
replacement parts for such a device and the procedures necessary to
implant, repair or replace a part of such a device; making an
appropriation; and providing other matters properly relating thereto.
Legislative Counsel’s Digest:
1 Existing law requires the Department of Health and Human Services to administer the
2 Medicaid program. (NRS 422.270) [This] Section 2 of this bill requires the Director of the
3 Department to submit to the United States Secretary of Health and Human Services a request
4 to [amend] include under Medicaid to provide rates of reimbursement greater than or equal to
5 82 percent of the cost for: (1) a vagus nerve stimulation therapy device [;] prescribed for the
6 treatment of epilepsy; (2) any replacement part for such a device; and (3) the procedure
7 necessary to implant, repair or replace a part of such a device. [This bill] Section 2 also
8 clarifies that the rates of reimbursement established for the cost of a vagus nerve stimulation
9 therapy device and any replacement part for such a device must be separate from and in
10 addition to the rates of reimbursement for medical care necessary for the implantation or
11 repair of such a device or the replacement of a part for the device. Section 1 of this bill
12 makes an appropriation to and authorizes expenditures by the Division of Health Care
13 Financing and Policy of the Department for certain costs associated with making the
14 increases to rates of reimbursement under Medicaid required by section 2.
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
1 Section 1. 1. There is hereby appropriated from the State General
2 Fund to the Division of Health Care Financing and Policy of the Department
3 of Health and Human Services for carrying out the provisions of section 2 of

Assembly Amendment No. 893 to Assembly Bill No. 284 First Reprint Page 4
1 this act and making upgrades to computer systems necessary to carry out
2 those provisions the following sums:
3 For the Fiscal Year 2025-2026 ....................................................... $54,728
4 For the Fiscal Year 2026-2027 ..................................................... $240,004
5 2. Any balance of the sums appropriated by subsection 1 remaining at
6 the end of the respective fiscal years must not be committed for expenditure
7 after June 30 of the respective fiscal years by the entity to which the
8 appropriation is made or any entity to which money from the appropriation is
9 granted or otherwise transferred in any manner, and any portion of the
10 appropriated money remaining must not be spent for any purpose after
11 September 18, 2026, and September 17, 2027, respectively, by either the entity
12 to which the money was appropriated or the entity to which the money was
13 subsequently granted or transferred, and must be reverted to the State
14 General Fund on or before September 18, 2026, and September 17, 2027,
15 respectively.
16 3. Expenditure of the following sums not appropriated from the State
17 General Fund or the State Highway Fund is hereby authorized by the Division
18 of Health Care Financing and Policy of the Department of Health and Human
19 Services for the same purposes as set forth in subsection 1:
20 For the Fiscal Year 2025-2026 ..................................................... $188,270
21 For the Fiscal Year 2026-2027 ..................................................... $700,098
22 [Section 1.] Sec. 2. 1. On or before October 1, 2025, the Director of the
23 Department of Health and Human Services shall submit to the United States
24 Secretary of Health and Human Services a request to include under Medicaid:
25 (a) A rate of reimbursement for a vagus nerve stimulation therapy device
26 prescribed for the treatment of epilepsy that is greater than or equal to 82 percent
27 of the acquisition cost of such a device;
28 (b) A rate of reimbursement for any replacement part for a vagus nerve
29 stimulation therapy device prescribed for the treatment of epilepsy that is greater
30 than or equal to 82 percent of the acquisition cost of such a replacement part; and
31 (c) A rate of reimbursement for the procedure necessary to implant, repair or
32 replace a part of a vagus nerve stimulation therapy device prescribed for the
33 treatment of epilepsy that is greater than or equal to 82 percent of the cost of the
34 procedure.
35 2. The rates of reimbursement established pursuant to paragraphs (a) and (b)
36 of subsection 1 must be separate from and in addition to the rates of reimbursement
37 for the medical care necessary for implantation or repair of a vagus nerve
38 stimulation therapy device or the replacement of a part for such a device.
39 3. The request submitted pursuant to subsection 1 must be supported using
40 methods for determining rates of reimbursement accepted by the Secretary.
41 [Sec. 2.] Sec. 3. 1. This [act becomes] section and section 1 of this act
42 become effective [upon passage and approval.] on July 1, 2025.
43 2. Section 2 of this act becomes effective on March 1, 2026.

[DELETED:   A  D  ( T P J DN SI  IA L   | A L  C N   | C N  R N   | R N  ]
[DELETED:  PBN.AB-M I O S RNA2  t D o t D o H a H t s t e c r o r M f c d t t e EE M f v n s t d r o r a p o s a d m aE   S 1  1  T i h a f t S G F o]
[DELETED:  P t a a m u t c s n t c o t F F  2  A t a J 3 o t r f y b t e t w t a g o o t i a m a a p o t a m r m n b s f a p a S t s g o t a m b r t t S G F o o b S 1 2 a S 1 2 r  3  E G o S F F  [ 1  S 2  1  O D o H a H S s s t t U S S  ( A r o r f a v n s t d p o  ( A r o r f a r p f a v n s t  ( A r a p o a v n s d p f t t p  2  T o f t m c n f i o r o a v n s  3  T m  [ 2  S 3  1  T b  2  S]